Recently, Minnesotans have been receiving unsolicited, unrequested at-home colon cancer screening kits from health insurers, ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

If you're in your 40s, you might think colon cancer is something to worry about decades from now. But alarming new research ...

Health insurance companies send all kinds of things in the mail: brochures about benefits, branded items such as coasters and duffel bags, and reminders to get certain health tests done. Some have ...

A new way to screen for colon cancer is giving Americans more options to spot the disease in its early stages. According to the American Cancer Society, 1-in-3 adults do not get screened as ...

A new type of blood test can detect colon cancer with nearly a 90 percent accuracy rate, a potential breakthrough in the epidemic. A new study from researchers at New York University found the ...

Guardant Health is breaking barriers and hoping to get more people screened through the "Shield" test. For more News, Weather, and Sports in Panama City, Florida visit: https://www.mypanhandle.com ...

Guardant’s test analyzes circulating tumor DNA that is then used to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from treatment with the Braftovi combo therapy ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

But you’ll need to test more frequently, every one to three years instead of every 10 years for a colonoscopy. Anyone with an ...

A new artificial intelligence tool can identify whether a patient is ready for colonoscopy by simply analyzing stool images that they take on their smartphones.

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.